Successful antibody behind the billion crown Life Science deal
This article is over 5 years old, and the information may therefore be outdated. An antibody that did not fulfil its purpose against the disease multiple sclerosis, MS, instead made its big break in cancer research and is now starring in southern Sweden’s largest licensing agreement in Life Science history. The “father” of the antibody is Professor Carl Borrebaeck. It is one of the windiest days i
https://www.lunduniversity.lu.se/article/successful-antibody-behind-billion-crown-life-science-deal - 2026-05-03
